• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏功率血流动力学测量在心血管疾病评估和风险分层中的应用

Utility of Cardiac Power Hemodynamic Measurements in the Evaluation and Risk Stratification of Cardiovascular Conditions.

作者信息

Farshadmand Jonathan, Lowy Zachary, Hai Ofek, Zeltser Roman, Makaryus Amgad N

机构信息

Donald and Barbara School of Medicine at Hofstra/Northwell, Hofstra University, 500 Hofstra Blvd., Hempstead, NY 11549, USA.

Department of Cardiology, Nassau University Medical Center, Hempstead, NY 11554, USA.

出版信息

Healthcare (Basel). 2022 Nov 30;10(12):2417. doi: 10.3390/healthcare10122417.

DOI:10.3390/healthcare10122417
PMID:36553940
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9777954/
Abstract

Despite numerous advancements in prevention, diagnosis and treatment, cardiovascular disease has remained the leading cause of mortality globally for the past 20 years. Part of the explanation for this trend is persistent difficulty in determining the severity of cardiac conditions in order to allow for the deployment of prompt therapies. This review seeks to determine the prognostic importance of cardiac power (CP) measurements, including cardiac power output (CPO) and cardiac power index (CPI), in various cardiac pathologies. CP was evaluated across respective disease-state categories which include cardiogenic shock (CS), septic shock, transcatheter aortic valve replacement (TAVR), heart failure (HF), post-myocardial infarction (MI), critical cardiac illness (CCI) and an "other" category. Literature review was undertaken of articles discussing CP in various conditions and this review found utility and prognostic significance in the evaluation of TAVR patients with a significant correlation between one-year mortality and CPI; in HF patients showing CPI and CPO as valuable tools to assess cardiac function in the acute setting; and, additionally, CPO was found to be an essential tool in patients with CCI, as the literature showed that CPO was statistically correlated with mortality. Cardiac power and the derived measures obtained from this relatively easily obtained variable can allow for essential estimations of prognostic outcomes in cardiac patients.

摘要

尽管在预防、诊断和治疗方面取得了诸多进展,但在过去20年里,心血管疾病一直是全球主要的死亡原因。这种趋势的部分原因在于,确定心脏疾病的严重程度以进行及时治疗一直存在困难。本综述旨在确定心脏功率(CP)测量,包括心脏功率输出(CPO)和心脏功率指数(CPI),在各种心脏疾病中的预后重要性。在包括心源性休克(CS)、感染性休克、经导管主动脉瓣置换术(TAVR)、心力衰竭(HF)、心肌梗死后(MI)、重症心脏疾病(CCI)以及“其他”类别等各自的疾病状态类别中对CP进行了评估。对讨论各种情况下CP的文章进行了文献综述,本综述发现,在评估TAVR患者时,CP具有实用性和预后意义,一年死亡率与CPI之间存在显著相关性;在HF患者中,CPI和CPO是评估急性情况下心脏功能的有价值工具;此外,在CCI患者中,CPO是一种重要工具,因为文献表明CPO与死亡率存在统计学相关性。心脏功率以及从这个相对容易获得的变量得出的测量值,可以对心脏病患者的预后结果进行重要评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee73/9777954/6badd8860ddf/healthcare-10-02417-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee73/9777954/6badd8860ddf/healthcare-10-02417-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee73/9777954/6badd8860ddf/healthcare-10-02417-g001.jpg

相似文献

1
Utility of Cardiac Power Hemodynamic Measurements in the Evaluation and Risk Stratification of Cardiovascular Conditions.心脏功率血流动力学测量在心血管疾病评估和风险分层中的应用
Healthcare (Basel). 2022 Nov 30;10(12):2417. doi: 10.3390/healthcare10122417.
2
Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry.心脏功率是心源性休克死亡率最强的血流动力学相关因素:来自SHOCK试验注册研究的报告
J Am Coll Cardiol. 2004 Jul 21;44(2):340-8. doi: 10.1016/j.jacc.2004.03.060.
3
["Cardiac power output" an old tool, possibly a modern tool for assessing cardiac pumping capability, as well as for a short-term prognosis in cardiogenic shock due to acute myocardial infarction].["心脏输出功率",一种旧工具,可能也是一种用于评估心脏泵血能力以及急性心肌梗死所致心源性休克短期预后的现代工具]
Arch Cardiol Mex. 2006 Jan-Mar;76(1):95-108.
4
Does Resting Cardiac Power Index Affect Survival Post Transcatheter Aortic Valve Replacement?静息心脏功率指数是否影响经导管主动脉瓣置换术后的生存?
J Invasive Cardiol. 2020 Apr;32(4):129-137. doi: 10.25270/jic/19.00361. Epub 2020 Mar 20.
5
Cardiac power output predicts mortality across a broad spectrum of patients with acute cardiac disease.心脏输出功率可预测各类急性心脏疾病患者的死亡率。
Am Heart J. 2007 Mar;153(3):366-70. doi: 10.1016/j.ahj.2006.11.014.
6
Prognostic value of resting cardiac power index depends on mean arterial pressure in dilated cardiomyopathy.静息心功率指数的预后价值取决于扩张型心肌病的平均动脉压。
ESC Heart Fail. 2021 Aug;8(4):3206-3213. doi: 10.1002/ehf2.13446. Epub 2021 May 27.
7
Prognostic value of right atrial pressure-corrected cardiac power index in cardiogenic shock.右心房压力校正心功率指数在心源性休克中的预后价值。
ESC Heart Fail. 2022 Dec;9(6):3920-3930. doi: 10.1002/ehf2.14093. Epub 2022 Aug 11.
8
Evaluation of Resting Cardiac Power Output as a Prognostic Factor in Patients with Advanced Heart Failure.静息心输出量作为晚期心力衰竭患者预后因素的评估
Am J Cardiol. 2017 Sep 15;120(6):973-979. doi: 10.1016/j.amjcard.2017.06.028. Epub 2017 Jun 28.
9
Cardiovascular outcomes and trends of Transcatheter vs. Surgical aortic valve replacement among octogenarians with heart failure: A Propensity Matched national cohort analysis.老年心力衰竭患者经导管与外科主动脉瓣置换术的心血管结局及趋势:一项倾向匹配的全国队列分析
Int J Cardiol Heart Vasc. 2022 Sep 15;42:101119. doi: 10.1016/j.ijcha.2022.101119. eCollection 2022 Oct.
10
Does a Gradient-Adjusted Cardiac Power Index Improve Prediction of Post-Transcatheter Aortic Valve Replacement Survival Over Cardiac Power Index?梯度校正的心脏做功指数是否比心脏做功指数更能提高经导管主动脉瓣置换术后的生存预测?
Yonsei Med J. 2020 Jun;61(6):482-491. doi: 10.3349/ymj.2020.61.6.482.

引用本文的文献

1
Futility in TAVI: A scoping review of definitions, predictive criteria, and medical predictive models.经导管主动脉瓣植入术(TAVI)中的无效治疗:定义、预测标准及医学预测模型的范围综述
PLoS One. 2025 Jan 9;20(1):e0313399. doi: 10.1371/journal.pone.0313399. eCollection 2025.
2
Correction: Farshadmand et al. Utility of Cardiac Power Hemodynamic Measurements in the Evaluation and Risk Stratification of Cardiovascular Conditions. 2022, , 2417.更正:法尔沙德蒙德等人。心脏功率血流动力学测量在心血管疾病评估和风险分层中的应用。2022年,,2417。 (注:原文中存在一些格式不清晰的地方,可能影响准确理解。)
Healthcare (Basel). 2023 Aug 17;11(16):2323. doi: 10.3390/healthcare11162323.

本文引用的文献

1
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
2
Right Atrial Pressure Predicts Mortality Among LVAD Recipients: Analysis of the INTERMACS Database.右心房压力预测 LVAD 受者死亡率:INTERMACS 数据库分析。
Heart Lung Circ. 2021 Apr;30(4):592-599. doi: 10.1016/j.hlc.2020.10.018. Epub 2020 Nov 20.
3
Artificial Intelligence Trumps TAVI-SCORE and CoreValve Score in Predicting 1-Year Mortality Post-Transcatheter Aortic Valve Replacement.
人工智能在预测经导管主动脉瓣置换术后 1 年死亡率方面优于 TAVI-SCORE 和 CoreValve 评分。
Cardiovasc Revasc Med. 2021 Mar;24:33-41. doi: 10.1016/j.carrev.2020.08.010. Epub 2020 Aug 15.
4
Noninvasive Hemodynamic Assessment of Shock Severity and Mortality Risk Prediction in the Cardiac Intensive Care Unit.非侵入性血流动力学评估在心脏重症监护病房中的休克严重程度和死亡率风险预测。
JACC Cardiovasc Imaging. 2021 Feb;14(2):321-332. doi: 10.1016/j.jcmg.2020.05.038. Epub 2020 Aug 19.
5
Cardiac Power Output Index and Severe Primary Graft Dysfunction After Heart Transplantation.心脏输出功率指数与心脏移植后严重原发性移植物功能障碍。
J Cardiothorac Vasc Anesth. 2021 Feb;35(2):398-403. doi: 10.1053/j.jvca.2020.07.020. Epub 2020 Jul 10.
6
Does a Gradient-Adjusted Cardiac Power Index Improve Prediction of Post-Transcatheter Aortic Valve Replacement Survival Over Cardiac Power Index?梯度校正的心脏做功指数是否比心脏做功指数更能提高经导管主动脉瓣置换术后的生存预测?
Yonsei Med J. 2020 Jun;61(6):482-491. doi: 10.3349/ymj.2020.61.6.482.
7
Does Resting Cardiac Power Index Affect Survival Post Transcatheter Aortic Valve Replacement?静息心脏功率指数是否影响经导管主动脉瓣置换术后的生存?
J Invasive Cardiol. 2020 Apr;32(4):129-137. doi: 10.25270/jic/19.00361. Epub 2020 Mar 20.
8
Non-invasive hemodynamic profiling of patients undergoing hemodialysis - a multicenter observational cohort study.接受血液透析患者的非侵入性血流动力学分析-一项多中心观察性队列研究。
BMC Nephrol. 2019 Sep 3;20(1):347. doi: 10.1186/s12882-019-1542-4.
9
Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative.休克方案的应用与改善预后相关:国家心源性休克倡议的最新进展。
Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1173-1183. doi: 10.1002/ccd.28307. Epub 2019 Apr 25.
10
Standardized Team-Based Care for Cardiogenic Shock.标准化的以团队为基础的心源性休克治疗方案。
J Am Coll Cardiol. 2019 Apr 9;73(13):1659-1669. doi: 10.1016/j.jacc.2018.12.084.